That’s due to a handful of catalysts that could boost the beaten-down corner of the market, according to Sean Laaman, a US small- and mid-cap biotech analyst, and Terence Flynn, a US biopharma analyst …
Morgan Stanley sees one beaten-down area of the stock market that could soon roar back to life
view original post